X

Vous n'êtes pas connecté

  - NEWS.MEDICAL.NET - A la Une - 26/Jun 14:19

Epigenetic enzyme SETD1B drives aggressive growth in acute myeloid leukemia

Acute myeloid leukemia (AML) is an aggressive cancer affecting the blood and bone marrow that progresses rapidly, making immediate treatment essential.

Articles similaires

Sorry! Image not available at this time

Acute Myeloid Leukemia: Expert Explains Why This Aggressive Blood Cancer Is Rising Fast In India

zeenews.india.com - 22/Jun 10:41

AML is a silent but deadly blood cancer that’s claiming Indian lives due to delayed diagnosis and lack of access, here’s what an expert wants you...

Sorry! Image not available at this time

Acute Myeloid Leukemia: Expert Explains Why This Aggressive Blood Cancer Is Rising Fast In India

zeenews.india.com - 22/Jun 10:41

AML is a silent but deadly blood cancer that’s claiming Indian lives due to delayed diagnosis and lack of access, here’s what an expert wants you...

Targeting fusion protein’s role in childhood leukaemia produces striking results

oncologynews.com.au - 27/Jun 14:47

Scientists at St. Jude Children’s Research Hospital and Dana-Farber Cancer Institute, USA, report the identification of a novel combination therapy...

Targeting fusion protein’s role in childhood leukaemia produces striking results

oncologynews.com.au - 27/Jun 14:47

Scientists at St. Jude Children’s Research Hospital and Dana-Farber Cancer Institute, USA, report the identification of a novel combination therapy...

Fanconi Anemia: Gene Discovery Opens New Doors for Treatment

medindia.net - 21/Jun 20:54

bFanconi anemia is a serious and potentially fatal inherited disorder. /b Marked by bone marrow failure and an increased risk of...

Blood test can reveal early signs of leukemia without bone marrow sampling

news.medical.net - 00:27

What if a blood test could reveal the pace of our aging – and the diseases that may lie ahead? The labs of Profs. Liran Shlush and Amos Tanay at the...

Sorry! Image not available at this time

Servier India introduces 'Ivosidenib' in India, first─in─class targeted therapy in oncology for rare IDH1─mutated AML & CCA

pharmabiz.com - 21/Jun 21:02

Servier India, a subsidiary of the leading French pharmaceutical Servier Group, recently announced the launch of Ivosidenib (Tibsovo), an oral...

Sorry! Image not available at this time

Servier India introduces 'Ivosidenib' in India, first─in─class targeted therapy in oncology for rare IDH1─mutated AML & CCA

pharmabiz.com - 21/Jun 21:02

Servier India, a subsidiary of the leading French pharmaceutical Servier Group, recently announced the launch of Ivosidenib (Tibsovo), an oral...

Blood-Based Epigenetic Clock Tracks Aging Through Intrinsic Capacity

medindia.net - 21/Jun 20:54

Researchers have developed a novel blood-based epigenetic clock that estimates an individual's biological age by measuring intrinsic capacity (IC)...

Blood-Based Epigenetic Clock Tracks Aging Through Intrinsic Capacity

medindia.net - 21/Jun 20:54

Researchers have developed a novel blood-based epigenetic clock that estimates an individual's biological age by measuring intrinsic capacity (IC)...

Les derniers communiqués

  • Aucun élément